Introduction {#s0001}
============

tRNAs (tRNAs) are the central adaptors in the translation process responsible for decoding mRNAs. tRNAs harbor numerous post-transcriptional modifications that fine-tune their function. To date, more than 90 modifications[@cit0001] have been identified in tRNA, and most organisms devote more genetic information to modifying tRNAs than to the tRNAs themselves.[@cit0002] While modifications have been shown to affect different aspects of tRNA metabolism and shape interactions of tRNA molecules with the rest of the translation apparatus,[@cit0003] most modifications to the anticodon-stem-loop (ASL) are required for accurate decoding.[@cit0006] The diversity of tRNA modifications and how modifications affect function has been the topic of recent reviews,[@cit0008] and for a summary of modifications to the ASL in *Escherichia coli* see the recent review by Helm and Alfonzo[@cit0011] and **Table 4** in de Crécy-Lagard, et al.[@cit0010] In this review, we address the enzymes responsible for the formation of N6-threonyl-carbamoyl-adenosine (t^6^A) and its derivatives. This complex modification of adenosine is located at position 37, next to the anticodon (t^6^A~37~), and is one of the few universal modifications of the ASL.[@cit0012] Table 1.Proposed names and functional roles for t^6^A synthesis genes.New NameOld NamesFunctionBacteria  TsaBYeaZ / YdiCtRNA adenosine(37) threonylcarbamoyltransferase complex, dimerization subunit type 1TsaCYrdC[L]{.smallcaps}-threonylcarbamoyladenylate synthase (~EC~ 2.7.7.87) type 1TsaC2Sua5 / YwlC[L]{.smallcaps}-threonylcarbamoyladenylate synthase (~EC~ 2.7.7.87) type 2TsaDYgjD / YdiEtRNA adenosine(37) threonylcarbamoyltransferase complex, transferase subunitTsaEYgjE / YdiBtRNA adenosine(37) threonylcarbamoyltransferase complex, ATPase subunit type 1Archaea / Eukaryotes  Tcs1YrdC[L]{.smallcaps}-threonylcarbamoyladenylate synthase (~EC~ 2.7.7.87) type 1Tcs2Sua5[L]{.smallcaps}-threonylcarbamoyladenylate synthase (~EC~ 2.7.7.87) type 2Tcs3Kae1 / gcp / OSGEPtRNA adenosine(37) threonylcarbamoyltransferase complex, transferase subunitTcs4Qri7 / OSGEPL1tRNA adenosine(37) threonylcarbamoyltransferase, mitochondrialTcs5Bud32tRNA adenosine(37) threonylcarbamoyltransferase complex, ATPase subunit type 2Tcs6Pcc1tRNA adenosine(37) threonylcarbamoyltransferase complex, dimerization subunit type 2Tcs7Cgi121tRNA adenosine(37) threonylcarbamoyltransferase complex, regulator subunitTcs8Gon7tRNA adenosine(37) threonylcarbamoyltransferase complex, fungal specific subunit Table 2.Homologs of t^6^A biosynthetic genes in Bacteria.OrganismTsaCTsaC2 (Sua5)TsaBTsaDTsaE*E. coli* K12b3282 b1807b3064b4168*Vibrio cholerae* O1 El TorVC0054VC1079VC1989VC0521VC0343*Caulobacter crescentus* NA1000CCNA_03501 CCNA_00057CCNA_00069CCNA_03648*Mycoplasm gentialium* G37MG259\* MG208MG046N.P.*Mycoplasm pulmonis*MYPU_6130^\#^ MYPU_1190MYPU_1180MYPU_1200*Bacillus subtilis* subsp. subtilis str. 168 BSU36950BSU05920BSU05940BSU05910*Haemophilus influenzae* RdHI0656 HI0388HI0530HI0065*Acinetobacter baylyi* APD1ACIAD0208 ACIAD0677ACIAD1332ACIAD2376*Salmonella* Typhii TY2STY4395 STY1950STY3387STY4714*Francisella novisida* U112FTN_0158 FTN_1148FTN_1565FTN_0274*Pseudomonas aeruginosa* PA01PA0022 PA3685PA0580PA4948*Burkholderia thailandensis* E264BTH_I0669 BTH_I2001BTH_II0616BTH_I0723*Stapholcoccus aureus* subsp *aureus* MW2MW0860MW2040MW1975MW1973MW1976[^1][^2][^3] Table 3.Homologs of t^6^A biosynthetic genes in Archaea and Eukarya.OrganismTcs1 YrdC)Tcs2 (Sua5)Tcs3 (Kae1)Tcs4 (Qri7)Tcs5 (Bud32)Tcs6 (Pcc1)Tcs7 (Cgi121)Tcs8 (Gon7)Haloferax volcanii DS2HVO_0253 HVO_1895^+^ HVO_1895 ^+^HVO_0652HVO_0013 Homo sapiens1p34.3 14q11.22q32.220q13.2Xq282p24.3-p24.1 Drosophila melanogasterCG10438 CG4933CG14231CG10673CG42498N.P. Plasmodium falciparum PFL0175cPF3D7_1030600 PF3D7_0408900.1^‡^N.P.MAL7P1.26N.P.PFE0580w Saccharomyces cerevisiae S228C YGL169wYKR038cYDL104cYGR262cYKR095w-AYML036wYJL184wSchizosaccharomyces pombe SPCC895.03cSPBC16D10.03SPCC1259.10SPAP27G11.07cSPAC4H3.13SPCC24B10.12SPAC6B12.18Arabidopsis thalianaAT5G60590 AT4G22720AT2G45270AT5G26110AT5G53045AT4G34412 [^4][^5][^6]

The hypermodified base t^6^A is present in nearly all ANN decoding tRNAs and has been studied in vitro and in vivo for more than 40 y.[@cit0013] Since the first discovery of the modification by Schweizer, et al. in 1969,[@cit0018] sporadic studies established the basic requirements for the synthesis of this universal modification, identifying the requirement for ATP, threonine and carbonate,[@cit0015] but fell short of elucidating the multi-step path to its formation. Subsequent studies in which native *E. coli* tRNA^fMet^ (harboring an unmodified A~37~) and yeast tRNA^iMet^ transcripts were converted to t^6^A~37~ after microinjection into *Xenopus laevis* oocytes demonstrated that the formation of t^6^A occurred in the oocyte cytoplasm and used a conserved machinery.[@cit0013] These studies also demonstrated that A~37~ and U~36~ were strict determinants for t^6^A formation, and that A~38~ enhances the efficiency of modification of A~37~ to t^6^A~37~.[@cit0013] Finally, structural studies showed that t^6^A enhances anticodon-codon base-pairing by cross-strand base-stacking of the t^6^A base with the first position of the codon,[@cit0023] and influences the structure of the ASL by preventing across the loop base-pairing between U33-A37, as well as stacking of bases A~37~ and A~38~.[@cit0023]

Only in the last 5 y have the t^6^A biosynthesis enzymes and the pathways been elucidated, revealing both a core set of enzymes and kingdom-specific variations ([**Fig. 1**](#f0001){ref-type="fig"}).[@cit0028] Elucidation of this multi-step pathway, which requires the formation of an activated carbon dioxide intermediate, and the diversity of the enzymes required for synthesis are the focus of this review. Figure 1.Diversity in the synthesis of the universal tRNA modification t^6^A. Two types of enzymes families, TsaC (YrdC) and TsaC2 (Sua5) in Bacteria and Tcs1 (YrdC) and Tcs2 (Sua5) in Eukarya and Archaea, catalyze the formation of TC-AMP. TsaC2 and Tcs2 contain a TsaC-domain plus an additional C-terminal Sua5-domain. To transfer threonylcarbamoyl (TC) to tRNA, Bacteria require TsaBDE, while Archaea and Eukarya use the KEOPS complex composed of Tcs3 (Kae1), Tcs5 (Bud32), Tcs6 (Pcc1) and Tcs7 (Cgi121) proteins. Tcs8 (Gon7) is found exclusively in Fungi. Mitochondria use the nuclear encoded Tcs4 (Qri7) for transfer of the TC to tRNA. Colors represent homology and correspond with [**Figure 2**](#f0002){ref-type="fig"}.

Discovery of the First t^6^A Synthesis Genes {#s0002}
============================================

The first enzyme of the t^6^A pathway was discovered in 2009 when it was found that a universal protein family, YrdC/Sua5 (COG0009), was involved in t^6^A modification.[@cit0031] Based on the assumption that because t^6^A was universally conserved the t^6^A biosynthetic enzymes would also be universally conserved, this work used comparative genomic analysis to focus on universally conserved protein families of unknown function. At the time of this study, 9 universally conserved protein families were of unknown function. Of these, the YrdC/Sua5 family was judged the most likely candidate for involvement in t^6^A biosynthesis due to: 1) its similarity to HypF, which catalyzes a carbamoylation reaction[@cit0034] similar to a putative step in t^6^A biosynthesis proposed in 1974 by both Elkins and Keller[@cit0015] and Körner and Söll;[@cit0017] 2) mutations in the yeast *yrdC* ortholog *SUA5* led to translation defects (initiation at non-AUG codons);[@cit0035] and 3) *E. coli* YrdC was found to bind RNA and tRNA.[@cit0036] The involvement of the YrdC/Sua5 family in t^6^A synthesis was experimentally validated using *E. coli* and *Saccharomyces cerevisiae*.[@cit0031]

In *E. coli*, *yrdC* is essential, but *SUA5* can be deleted from *S. cerevisiae*, although the growth of the mutant is severely compromised. tRNAs analyzed from this mutant were devoid of t^6^A. The levels of t^6^A could be restored through complementation with *SUA5~Sc~*, *yrdC~Ec~*, *ywlC~Bs~* (*Bacillus subtilis SUA5* homolog), and *yrdC~Mm~* (*Methanococcus maripaludis*, an archaeal *yrdC* homolog). The essentiality phenotype of a *E. coli yrdC* deletion could be complemented by expressing orthologs from yeast, *B. subtilis,* and *M. maripaludis in trans*.[@cit0031] Analysis of tRNAs in the complemented strains confirmed the presence of t^6^A.[@cit0031] This work identified the first gene family involved in t^6^A synthesis, established that its function is universally conserved, and that members of the family could bind ATP, but because purified YrdC alone was not sufficient to produce t^6^A in tRNA transcripts in vitro, it also suggested that additional enzymes were needed for t^6^A synthesis, or that the role of YrdC/Sua5 family was indirect.

A second protein family involved with t^6^A synthesis, YgjD/Kae1/Qri7 (COG0533), was discovered in 2011.[@cit0030] Like YrdC/Sua5, the YgjD/Kae1/Qri7 family of proteins is universally conserved, and also exhibited similarity to HypF, which harbors a fusion of YrdC-like and YgjD-like domains. Kae1 had first been described as a member of the KEOPS complex (Kinase, putative Endopeptidase and Other Proteins of Small size)[@cit0037] also known as EKC (Endopeptidase-like Kinase Chromatin-associated complex),[@cit0038] and had been proposed to be involved in a variety of phenomena unrelated to RNA modification.[@cit0037] A phylogeny of this family revealed that yeast harbored 2 members of the family.[@cit0039] The first, Kae1 had homologs in other eukaryotes and archaea, and the second, Qri7 was targeted to the mitochondria and was part of the bacterial YgjD clade.[@cit0039]

The hypothesis that the YgjD/Kae1/Qri7 family was involved in t^6^A synthesis was confirmed by extracting tRNAs from *S. cerevisiae kae1*Δ and showing they were devoid of t^6^A and that t^6^A levels could be restored by complementation with either *ygjD~Ec~* or a version of *QRI7~Sc~* designed to remain in the cytoplasm. These results also indicated that members of the YgjD/Kae1/Qri7 family were isofunctional for t^6^A synthesis, at least in yeast. To test if YgjD/Kae1/Qri7 were isofunctional in *E. coli*, a P~TET~::*ygjD* strain was constructed (*ygjD* is only expressed when anhydrotetracycline, aTc, is added). Only the expression of the *ygjD* gene from *E. coli* allowed complementation of the essentiality phenotype in the absence of aTc. In contrast to the YrdC/Sua5 complementation results, expression of the *KAE1~Sc~* and *QRI7~Sc~* genes from yeast, the *PRPK~Mm~* from *Methanococcus maripaludis* (PRPK is a fusion of Kae1-Bud32 in Archaea) or the *B. subtilis ygjD~Bs~* did not complement the essentiality phenotype of the absence of *ygjD*.

While the protein families TsaC/Sua5 and Kae1/Qri7/TsaD were found to be strictly required for the biosynthesis of t^6^A, and a homolog of at least one member of each family is found in all domains of life ([**Fig. 2**](#f0002){ref-type="fig"}),[@cit0030] YrdC and YgjD failed to produce t^6^A in vitro with transcript or t^6^A-deficient tRNA purified from yeast *sua5*Δ,[@cit0030] suggesting that the biosynthetic machinery for t^6^A biosynthesis required more than these 2 proteins. Over the last 2 years, a flurry of papers have reported the identification of these missing proteins, and elucidated the complete bacterial,[@cit0028] eukaryotic/archaeal,[@cit0029] and mitochondrial[@cit0032] biosynthetic pathways to t^6^A. Figure 2.Distribution of genes for biosynthesis of t^6^A and derivatives. Representative organisms from each domain of life were used to build a taxonomic tree in iToL (<http://itol.embl.de>).[@cit0073] Filled circles indicate presence of genes. Genes for formation of ct^6^A are collapsed into a single column.

Synthesis of t^6^A Varies With Domains of Life {#s0003}
==============================================

The observation that the YrdC/Sua5 family members were functionally interchangeable between domains[@cit0031] while YgjD/Kae1/Qri7 were not[@cit0030] lead to a model in which t^6^A biosynthesis occurred in 2 steps with kingdom, species, or organelles specific partners for the second step.

Bacteria {#s0003-0001}
--------

The identity of the remaining enzymes in bacterial t^6^A synthesis was predicted from 3 pieces of evidence. First, YgjD was shown to form an association network with YeaZ (a paralog of YgjD) and YjeE, based on physical interaction between the proteins and physical clustering of the genes;[@cit0030] second, like YrdC and YgjD, YeaZ and YjeE were essential in *E. coli;*[@cit0046] and third, complementation of the *E. coli yjgD*^-^ essentiality phenotype required expression of both *B. subtilis ygjD* and *yeaZ* genes, suggesting that a YgjD/YeaZ interaction was necessary for t^6^A synthesis.[@cit0030] Notably, it\'s been shown that only YeaZ-YgjD pairs from closely related organisms form complexes in vitro.[@cit0047] The final evidence that YeaZ and YjeE were the missing proteins in t^6^A bacterial synthesis was provided by in vitro reconstitution experiments,[@cit0028] which demonstrated that recombinant YrdC, YgjD, YeaZ, and YjeE proteins from *E. coli*[@cit0028] were collectively both necessary and sufficient to generate t^6^A in reactions with threonine, bicarbonate, ATP, and either *E. coli* tRNA^Thr^ or tRNA^Lys^ transcripts, or unfractionated tRNA from yeast *sua5*Δ. Notably, t^6^A formation was not observed when a tRNA transcript corresponding to tRNA^Gln^ from *Methanothermaobacter thermautotrophicus*, which does not naturally contain t^6^A, or a 17-mer corresponding to an unmodified ASL of *E. coli* tRNA^Lys^ were used as a substrates.[@cit0028] While the former was consistent with the natural lack of t^6^A in this tRNA, the latter was surprising since this ASL had previously been show to bind specifically to *E. coli* YrdC.[@cit0028] The t^6^A synthesis pathway was subsequently reconstituted using the *B. subtilis* enzymes YwlC (an ortholog of yeast Sua5), and YdiBCE (orthologs of *E. coli* YjeE, YeaZ, and YgjD, respectively),[@cit0033] demonstrating the universality of these enzymes in bacteria. With the newly established enzymatic role for YeaZ, YrdC, YgjD, and YjeE (and their orthologs) in the biosynthesis of [t]{.ul}hreonylcarbamoyl-[6]{.ul}-[a]{.ul}denosine (t^6^A), these enzymes were renamed TsaB, TsaC, TsaD, and TsaE, respectively ([**Fig. 1**](#f0001){ref-type="fig"}).[@cit0028]

Archaea and Eukarya {#s0003-0002}
-------------------

The TsaE and TsaB proteins in Bacteria have no homologs in Eukarya or Archaea. The identification of the additional components of t^6^A biosynthesis in these last 2 kingdoms came from the fact that Kae1 was part of the KEOPS/EKC complex. The other subunits of the KEOPS/EKC complex (Bud32, Cgi121, Pcc1, plus the fungal specific Gon7) were tested for a potential role in t^6^A synthesis, first genetically then in vitro. Mutation of *PCC1* and *BUD32,* but not in *CGI121,* in yeast eliminated t^6^A on tRNA^Ile^ reportedly by a primer extension assay.[@cit0041] However, the primer extension method reported by the Sternglanz laboratory has not been repeated by others. (de Crécy-Lagard laboratory, Goldberg laboratory, and Glavic laboratory, personal communication). Indeed, as recently shown by the Alfonzo laboratory, reverse-transcriptase bypassed t^6^A to stop downstream at m^3^C~32~.[@cit0048] Analysis of bulk tRNA from a *pcc1--4* allele by LC-MS/MS found t^6^A was reduced 30%.[@cit0042] HPLC and LC-MS/MS analysis of bulk tRNAs purified from whole gene deletions in *S. cerevisiae* found that the *bud32*Δ and *gon7*Δ strains were devoid of t^6^A, while t^6^A levels in the *pcc1*Δ and *cgi121*Δ strains were reduced 30% and 60%, respectively, versus wild-type (Thiaville and de Crécy-Lagard, unpublished data). In the halophilic Archaea *Haloferax volcanii*, the *kae1‑bud32* (gene fusion) and *cgi121* are essential, precluding a direct genetic test of their role in t^6^A biosynthesis, and deletion of *pcc1* had only a small decrease (∼16%) in total t^6^A content.[@cit0040]

Confirmation that the KEOPS/EKC complex was responsible for t^6^A formation came with in vitro reconstitution experiments. It was shown that both the KEOPS/EKC complex from *Pyrococcus abyssi* (Kae1, Bud32, Pcc1, and Cgi121), reconstituted from the individual genes expressed in *E. coli*, as well as the *S. cerevisiae* KEOPS complex (Kae1, Bud32, Pcc1, Cgi121, and Gon7), genes expressed in *E. coli* as a synthetic operon,[@cit0050] can form t^6^A in vitro, when combined with Sua5 from yeast or Archaea.[@cit0029]

Mitochondria {#s0003-0003}
------------

Yeast mitochondrial tRNAs contain t^6^A,[@cit0051] and while none the subunits of the KEOPS/EKC complex or Sua5 have paralogs targeted to the mitochondria,[@cit0052] the Kae1 homolog Qri7 was found to be targeted to the mitochondria in yeast,[@cit0039] *Caenorhabditis elegans,*[@cit0039] human,[@cit0054] rat,[@cit0054] and *Arabidopsis thaliana*.[@cit0054] It was subsequently demonstrated that the nuclear encoded Sua5 can localize to both the cytoplasm and to the mitochondria in yeast through the use of alternative translation initiation at 2, in-frame AUG sites.[@cit0044] Translation from the first AUG encoded a mitochondrial signal peptide, and Sua5 was localized to the mitochondria. Sua5 translated from the second AUG remained in the cytoplasm.[@cit0044] Co-expression of both Sua5 and Qri7 in *E. coli* complemented the TsaD essentiality when the expression of Qri7 alone did not,[@cit0044] suggesting that Qri7 could substitute for the KEOPS complex or the TsaBDE proteins. In addition, expression of *QRI7* in the cytoplasm of a *bud32*Δ yeast strain restored growth defects.[@cit0032] This was confirmed when it was demonstrated that a minimal system comprised of only Sua5 and Qri7 is sufficient to synthesize t^6^A in vitro.[@cit0032]

Thus, the enzyme families TsaC/Sua5 and TsaD/Kae1/Qri7 are shared in all organisms, and Bacteria additionally require TsaBE, while Archaea and Eukarya use the other components of the KEOPS complex. Interestingly, although TsaBDE, KEOPS, and Qri7 are functional analogs, only the TsaD/Kae1/Qri7 protein is shared among the 3 systems ([**Fig. 2**](#f0002){ref-type="fig"}), suggesting that this protein family along with the TsaC/Sua5 family were part of the ancestral t^6^A synthesis core present in the last universal common ancestor (LUCA).[@cit0039]

Mechanistic Analysis of the t^6^A Synthesis Machineries {#s0004}
=======================================================

Experiments probing the role of ATP in bacterial t^6^A formation demonstrated that both AMP and ADP were products, and that ATP consumption could be uncoupled from RNA modification, with TsaC being the source of AMP (in a threonine dependent process) and TsaD/TsaB/TsaE together producing ADP.[@cit0028] These observations were consistent with earlier mechanistic hypotheses[@cit0030] in which the ATP requirement in t^6^A biosynthesis was rationalized on the presumed need for 2 activated acyl intermediates during the course of t^6^A formation (*i.e.* acyl-phosphate and/or acyl-adenylate), the first a phosphocarboxy species (*e.g.* carboxyphosphate or carboxyadenylate; [**Fig. 3**](#f0003){ref-type="fig"}, intermediate I) activated for transfer to the nitrogen of either threonine or adenosine-37, and the second an N-carboxyphospho species activated for transfer to the remaining component (threonine or adenosine-37;[**Fig. 3**](#f0003){ref-type="fig"}, intermediate III). However, closer scrutiny of the TsaC reaction in the *B. subtilis* system revealed that the product was threonylcarbamoyl-adenylate (TC-AMP, [**Fig. 1**](#f0001){ref-type="fig"}),[@cit0033] an intermediate already activated for condensation with adenosine-37 of tRNA, thus obviating ADP formation as part of the activation steps proposed to be necessary in the biosynthesis of t^6^A. Furthermore, AMP formation by TsaC was shown to arise exclusively from hydrolysis of TC-AMP,[@cit0033] and that PP~i~ was the other product of the TsaC reaction, implying that formation of TC-AMP itself proceeds through an unusual direct carboxylation of threonine by CO~2~ or HCO~3~^-^ ([**Fig. 4**](#f0004){ref-type="fig"}). Figure 3.Early mechanistic proposal for the formation of t^6^A. P\* refers to an activated acylphosphate species, either a simple acyl monophosphate or an acyl AMP. Figure 4.Stepwise formation of t^6^A illustrating the intermediates in the pathway.

The role of ADP production in t^6^A biosynthesis remains cryptic; in the bacterial system, t^6^A can be generated without formation of ADP by supplying purified TC-AMP to a reaction containing TsaD/TsaB/TsaE in the absence of ATP,[@cit0033] while in Archaea and Eukarya formation of t^6^A appears to require the reaction of ATP to ADP,[@cit0055] although it does not appear to serve a direct role in the reaction. In Archaea, Pcc1, Kae1, and Bud32 are minimally required to produce t^6^A in vitro,[@cit0055] with Kae1 comprising the catalytic subunit responsible for condensing TC-AMP with tRNA. Bud32 was shown to be an ATPase in the presence of Kae1, while it autophosphorylates when it is in complex with Cgi121. Thus, Kae1 apparently modifies the phosphotransferase activity of Bud32 and switches it from a kinase to an ATPase.[@cit0055] It\'s unclear what the specific role of this ATPase activity is, as neither Bud32 or Cgi121 participate directly in the t^6^A reaction. Cgi1321 appears to regulate activity by acting as an effector, where it\'s binding significantly changes the conformation of Bud32.[@cit0055]

Overall, the chemistry of t^6^A formation bears similarities to the TobZ system,[@cit0056] an *O*-carbamoyltransferase comprised of a TsaC-like domain fused to a Kae1-like domain that carries out the carbamoylation of tobramycin to form nebramycin-5′. In the TobZ reaction, the TsaC domain catalyzes the conversion of carbamoylphosphate to carbamoyladenylate, while the Kae1 domain condenses the latter with tobramycin. Likewise, in t^6^A formation the TsaC/Sua5 homologs generate an adenylated intermediate, which then is condensed with tRNA by the TsaD/Kae1/Qri7 proteins. A notable difference in the systems is that in TobZ the initial substrate is carbamoyl phosphate, which undergoes a phosphotransfer reaction to generate carbamoyl adenylate. This interchange of phosphoryl moieties is chemically not necessary for the subsequent condensation of the carbamoyl group with tobramycin, as both species are activated for the coupling reaction. In t^6^A biosynthesis, the initial substrates for TsaC/Sua5 are threonine and CO~2~/HCO~3~^-^, which react first to form N-carboxythreonine followed by reaction with ATP to form TC-AMP.

Structural Organization of t^6^A Biosynthetic Proteins {#s0005}
======================================================

The highly reactive nature of TC-AMP is not compatible with a freely diffusible intermediate in the biosynthesis of t^6^A, and argues for the evolution of systems in which this intermediate is instead channeled, as in TobZ,[@cit0056] from its site of production in TsaC/Sua5 to a second active-site (presumably in TsaD/Kae1/Qri7) where it undergoes reaction with tRNA. A number of observations are consistent with this proposal. First is the fact that the KEOPS complex from both Eukarya and Archaea is known to be a stable quaternary complex.[@cit0029] Second, while the bacterial proteins do not form an isolable complex analogous to KEOPS, they do interact with one another as demonstrated by the analysis of the *E. coli* proteins in pull-down experiments, which demonstrated binding of TsaC to both TsaB and TsaD,[@cit0028] and binding of TsaB to both TsaE and TsaD.[@cit0028] Furthermore, the ability of *B. subtilis* YdiD (TsaD homolog) to complement the Δ*tsaD* essentiality phenotype in *E. coli* was dependent on co-expression of YdiB (TsaB homolog),^30^ while the ability of Qri7 to complement this phenotype was dependent on co-expression of Sua5.^44^ These observations are consistent with the requirement for specific physical interactions between these proteins necessary for function.

Additionally, crystallographic analysis has shown that protein-protein associations are conserved across the systems. For example, the crystal structure of Qri7 shows that dimerization is required for Qri7 function, and the dimerization surfaces for Qri7 are used by the archaeal/eukaryotic Kae1 binding to Pcc1 and the bacterial TsaD binding to TsaB.[@cit0032] Interestingly, although the Pcc1 subunit of KEOPS/EKC shares no sequence similarity to Qri7 or TsaD, Pcc1 engages Kae1 in a manner surprisingly similar to dimerization of Qri7 and TsaD-TsaB.[@cit0032]

Thus, in all 3 systems the ability of the constituent proteins to physically interact with one another appears to be a requirement for t^6^A biosynthesis.

Naming Convention {#s0006}
=================

The literature is polluted with a variety of names for each t^6^A synthesis protein and even for the complexes. With the defined enzymatic and biological function now established it is appropriate to unify the t^6^A nomenclature. For all Bacteria, we recommend the following suggestions, in agreement with Ken Rudd (Curator of EcoGene, U. of Miami) and published in Deutsch, et al., of TsaB, TsaC, TsaD and TsaE, to replace YeaZ, YrdC, YgjD, and YjeE, respectively. Additionally, Sua5 in bacteria should be renamed TsaC2. TsaC2 is defined as a protein containing both a TsaC and the additional C-terminal Sua5 domain. For Eukarya and Archaea, the use of Tcs ([t]{.ul}hreonyl-[c]{.ul}arbamoyl [s]{.ul}ynthesis) is recommended (in yeast, *TSA1* and *TSA2* are in use in yeast for thioredoxin). We recommend the following nomenclature: Tcs1 (YrdC), Tcs2 (Sua5), Tcs3 (Kae1), Tcs4 (Qri7), Tcs5 (Bud32), Tcs6 (Pcc1), Tcs7 (Cgi121), and Tcs8 (Gon7). A summary of the new and old names, as well as recommended functional descriptions can be found in[Table 1](#t0001){ref-type="table"}. Additionally, we recommend naming the bacterial TsaBDE complex as well as the archeal/eukaryotic KEOPS/EKC complex to [T]{.ul}hreonyl-[c]{.ul}arbamoly [T]{.ul}ransferase [C]{.ul}omplex (TCTC), which will be in keeping with nomenclature of other members of the carbamoyl transferase family. The TCTC family can be further subdivided into bacterial (bTCTC), archaeal (aTCTC), and eukaryal (eTCTC).

Distribution of the t^6^A Synthesis Genes Vary in Different Organisms {#s0007}
=====================================================================

Annotation for the first enzyme of t^6^A synthesis, in bacteria, is complicated by the fact that 2 forms are found (the TsaC or TsaC2) and that 50% of the genomes analyzed harbor a TsaC paralog, YciO, that does not have the same function and does not contain the conserved KRSN tetrad.[@cit0031] We reannotated all members of the COG0009 family (in 9176 bacterial genomes and all contained a TsaC or a TsaC2: 6745 contain TsaC (73%), 2846 contain TsaC2 (31%), and 859 (9%) contained both. In addition, 54% contained YciO ([**Fig. 2**](#f0002){ref-type="fig"}, and <http://tinyurl.com/t6A-bacteria>). To date, no clear pattern (phylogenetic or lifestyle) has emerged in terms of presence of TsaC or TsaC2, in any given genome and the functional differences between the 2 are not understood. Most bacteria contain both TsaB and TsaE; however, TsaE can be lost in symbiotic or intracellular bacteria, such as *Wolbachia* or *Mycoplasmas* (e.g., *Mycoplasma genitalium* and *Mycoplasma pneumoniae*). To date only 2 bacteria, *Mycoplasma haemofelis* and *Mycoplasma suis* strain Illinois, are missing both TsaB and TsaE[@cit0058] ([**Fig. 2**](#f0002){ref-type="fig"} and [**Table 2**](#t0002){ref-type="table"}). It seems these organisms harbor a mitochondrial like minimal t^6^A synthesis system (unless another unidentified protein has been recruited).

Like Bacteria, all Eukarya and Archaea contain either a homolog of Tcs1 (TsaC/YrdC) or Tcs2 (TsaC2/Sua5). We have found one organism that has both, the fungi *Pseudocercospora fijiensis* CIRAD86, also known as *Mycosphaerella fijiensis* CIRAD86 (NCBI Taxonomic ID: 383855). As with bacteria, there is not a clear phylogenetic inheritance between organisms with Tcs1 or Tcs2 in Archaea or Eukarya, but a taxonomic relationship does exists in eukaryotes. Fungi exclusively contain Tcs2 (with *P. fijiensis* as an exception), while all Plants (including *Chlamydomonas reinhardtii*) and all Metazoans exclusively contain Tcs1. Of the 53 Archaea analyzed, 25 contain Tcs1 and 28 contain Tcs2. The only taxonomic relationship found is in the order Halobacteriales that exclusively contain Tcs1, [**Figure 2**](#f0002){ref-type="fig"} and [**Table 3**](#t0003){ref-type="table"} (<http://tinyurl.com/t6A-Arc-Euk>).

All Archaea contain a single Tcs3 (Kae1) homolog, while Eukarya also contain a single Tcs3 homolog and also have a Tcs4 (Qri7) homolog (evolutionarily related to the bacterial TsaD), which will function in the organelles. In all genomes analyzed, both Tcs3 and Tcs4 were found in the nuclear genome and not in the organelle. Specifically, the human nuclear genome contains Tcs3 (OSGEP) for cytoplasmic t^6^A synthesis and Tcs4 (OSGEPL1) was shown to target to the mitochondria.[@cit0054] Note to the reader, the Oberto, et al. paper incorrectly referred to OSGEPL as the Tcs4 homolog (instead of OSGEPL1), the human mitochondrial targeting protein. As an example for plants, *Arabidopsis thaliana* contains nuclear encoded Tcs3 (AT4G22720) and Tcs4 (AT2G45270). Tcs4*~At~* contains a strong chloroplast targeting signal, but has only been detected in the mitochondria.[@cit0054] The human pathogen *Plasmodium falciparum* (causative agent of malaria) presents an interesting case for t^6^A synthesis, as the mitochondria utilize fully modified cytoplasmic tRNAs for mitochondrial translation (requirement for t^6^A machinery is unknown), and *P. falciparum* contains an apicoplast originating from secondary endosymbiosis of an alage.[@cit0059] *P. falciparum* contains 2 nuclear encoded homologs of Tcs3 ([**Table 3**](#t0003){ref-type="table"}): a Tcs3 that is similar to the yeast Tcs3, and an apicoplast-targeting Tcs3b, that is similar to Tcs3,^60^ but is phylogenetically distant from all known Tcs3 and from the bacterial TsaD (Thiaville and de Crécy-Lagard, unpublished). Tcs3 interacts with both Tcs5 (Bud32) and Tcs7 (Cgi121), and Tcs3b interacts with multiple proteins associated with the apicoplast ribosome (Mallari and Goldberg, personal communication). Tcs2 has not been detected in the apicoplast, and it is currently unknown how the first step in t^6^A synthesis occurs. (Mallari and Goldberg, personal communication).

Tcs5 (Bud32) is found in all Eukarya and Archaea sequenced to date. In the 53 Archaea analyzed, Tcs5 and Tcs3 are adjacent ORFs in 13 genomes and are fused in 25 genomes, demonstrating a strong functional linkage between the proteins of these genes. Tcs6 (Pcc1) and Tcs7 (Cgi121) are found in nearly all Archaea and Eukarya. Notable exceptions are the absence of Tcs6 in *P. falciparum* and the absence of Tcs7 in *Drosophila melanogaster*. Tcs8 (Gon7) is a fungal specific protein. Tcs8 is required for t^6^A formation in yeast (Thiaville and de Crécy-Lagard, unpublished), but the function of Tcs8 is currently unknown.

Derivatives of t^6^A {#s0008}
====================

Currently, there are 3 known derivatives of t^6^A: ct^6^A (cyclic t^6^A), m^6^t^6^A (*N*^6^-methyl-*N*^6^-threonycarbamoyladenosine), and ms^2^t^6^A (2-methylthio-*N*^6^-threonycarbamoyladenosine).[@cit0001]

A new twist in the t^6^A field was recently discovered with the identification of cyclic form of t^6^A (ct^6^A), a cyclized active ester of t^6^A with an oxazolone ring.[@cit0061] Renumber starting here throughout the end of the manuscript. TcdA (previously CsdL in *E. coli*) catalyzes an ATP-dependent dehydration of t^6^A to ct^6^A; this reaction is performed by Tcd1 (YHR003c) and by Tcd2 (YKL027w) in yeast.[@cit0060] The harsh treatment for preparing tRNAs for LC-MS/MS analysis had masked the presence of the true arrangement of t^6^A, and ct^6^A appears to help tRNA^Lys^ decode the noncognate codons AGA and UAG.[@cit0060] At least for *E. coli*, ct^6^A appears to occur on all t^6^A-modified tRNAs.[@cit0060] Unlike TsaB, C, D, and E, TcdA is not essential for *E. coli* (minor growth defect), and is not universally conserved in bacteria ([**Fig. 2**](#f0002){ref-type="fig"}).[@cit0060] Whether this represents the final functional form of t^6^A, or if this a species-specific solution for a particular problem has not been addressed. Additionally, Tcd1 and Tcd2 localize to the outer membrane, not to the surface of yeast mitochondria,[@cit0061] and mutations in either render cells mitochondrial deficient.[@cit0060] How yeast cytoplasmic tRNAs would be converted to ct^6^A is currently unknown. Also, neither ct^6^A nor homologs of TcdA have been found in Archaea, and ct^6^A does not occur in humans[@cit0060] ([**Fig. 2**](#f0002){ref-type="fig"}).

The second known derivative of t^6^A, m^6^t^6^A, was initially thought to only occur in *E. coli* on the 2 tRNA^Thr^~(GGU)~ species that decode ACC and ACU.[@cit0062] The limited distribution of m^6^t^6^A is confounded by the small number of organisms in which tRNAs have been sequenced.[@cit0007] m^6^t^6^A is formed by TsaA (*E. coli* YaeB was recently identified as the gene responsible for TsaA activity, and renamed TrmO)[@cit0063] by transferring a methyl group from *S*-adenosylmethionine (AdoMet) to tRNA^Thr^~(GGU)~ containing t^6^A.[@cit0062] TrmO has a unique single-sheeted β-barrel structure and does not belong to any known classes of methyltransferases, representing a novel category of AdoMet-dependent methyltransferase (Class VIII). Interestingly, t^6^A is required for the formation of the m^6^ moiety at position 37 of tRNA^Thr^~(GGU)~, and in Δ*trmO*, tRNA^Thr^~(GGU)~ A~37~ will be modified to ct^6^A, suggesting that t^6^A is a common precursor to both m^6^t^6^A and ct^6^A.[@cit0063] m^6^t^6^A slightly improves translational efficiency at the codon ACY.[@cit0062] TrmO is widely distributed throughout life and cross-kingdom functional analysis was performed to show the activity was conserved.[@cit0063] ([**Fig. 2**](#f0002){ref-type="fig"})

The third known derivative of t^6^A, ms^2^t^6^A, is found only on tRNA^Lys^~(UUU)~ in a subset of organisms.[@cit0001] Particularly, ms^2^t^6^A is found in *B. subtilis*, some Archaea, and in human, but not in *E. coli*. YqeV (MtaB) in *B. subtilis* and Cdkal1 in humans are responsible for the insertion of the sulfur moiety and methylation at position 2 of the adenosine containing t^6^A.[@cit0064] MtaB has been shown to increase the accuracy of decoding lysine codons.[@cit0065] Loss of the Cdkal1 homolog in mice is correlated to increase Type 2 diabetes.[@cit0066] It is not clear if ct^6^A is the base to form ms^2^t^6^A, or like m^6^t^6^A, ms^2^t^6^A is formed from t^6^A. ([**Fig. 2**](#f0002){ref-type="fig"}).

Concluding Remarks {#s0009}
==================

The biosynthesis of t^6^A is just one example of a "rediscovery" of tRNA modifications in the genomic era, which has allowed for the discovery of globally unknown genes for enzyme reactions that were discovered more than 40 y earlier. In Bacteria, the 4 genes involved in t^6^A biosynthesis, due to their prokaryotic-specific essentiality and because *tsaB* and *tsaE* are found only in bacteria, had been identified as potential antibacterial and inhibitor targets prior to the discovery of their role in t^6^A synthesis was even established.[@cit0045] The unique Tcs3b found in *P. falciparum* also presents itself as an attractive anti-malarial target. For these proteins to be viable targets, it is critical to understand their distribution profile and potential range of action as well as the mechanisms underlying the essentiality phenotypes to predict resistance mechanisms. Clearly, one should use caution in designing drugs targeting TsaB and TsaE in *Mycoplasmas* spp. since the genes are absent. Caution would also be needed for drugs targeting TsaC, due to the possibility of cross reactivity in humans, although TsaC2 and TsaD may be viable options.

The discovery of the t^6^A pathways now allows us to address more systematically the causes of the pleiotropic phenotypes caused by the absence of t^6^A synthesis enzymes. Are these due to mistranslation of target proteins, to a role of t^6^A as a determinant for other components of the translation apparatus, or to a role of t^6^A or of t^6^A synthesis proteins in other processes than translation? Indeed, the recent discovery of a molecule similar to the t^6^A nucleoside in dauer signaling in nematodes[@cit0072] opens an unforeseen role for t^6^A derivatives in biology.
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[^1]: *M. gentialium* MG259 is a TsaC/HemK fusion.

[^2]: *M. pulmonis* TsaC (MYPU_6130) and HemK (MYPU_1060).

[^3]: N.P.: Not Present.

[^4]: *H. volcanii* Tcs3 and Tcs5 occur as a gene fusion (HVO_1895).

[^5]: *P. falciparum* PF3D7_0408900.1 (Tcs3b) targets to the apicoplast and is similar to Tcs3.

[^6]: N.P.: Not Present.
